| First Author | Shen C | Year | 2024 |
| Journal | Nat Immunol | Volume | 25 |
| Issue | 11 | Pages | 2085-2096 |
| PubMed ID | 39402152 | Mgi Jnum | J:361562 |
| Mgi Id | MGI:7859579 | Doi | 10.1038/s41590-024-01988-6 |
| Citation | Shen C, et al. (2024) Inflammasome protein scaffolds the DNA damage complex during tumor development. Nat Immunol 25(11):2085-2096 |
| abstractText | Inflammasome sensors activate cellular signaling machineries to drive inflammation and cell death processes. Inflammasomes also control the development of certain diseases independently of canonical functions. Here, we show that the inflammasome protein NLR family CARD domain-containing protein 4 (NLRC4) attenuated the development of tumors in the Apc(min/+) mouse model. This response was independent of inflammasome signaling by NLRP3, NLRP6, NLR family apoptosis inhibitory proteins, absent in melanoma 2, apoptosis-associated speck-like protein containing a caspase recruitment domain, caspase-1 and caspase-11. NLRC4 interacted with the DNA-damage-sensing ataxia telangiectasia and Rad3-related (ATR)-ATR-interacting protein (ATRIP)-Ewing tumor-associated antigen 1 (ETAA1) complex to promote the recruitment of the checkpoint adapter protein claspin, licensing the activation of the kinase checkpoint kinase-1 (CHK1). Genotoxicity-induced activation of the NLRC4-ATR-ATRIP-ETAA1 complex drove the tumor-suppressing DNA damage response and CHK1 activation, and further attenuated the accumulation of DNA damage. These findings demonstrate a noninflammatory function of an inflammasome protein in promoting the DNA damage response and mediating protection against cancer. |
